Organon (OGN) interim manufacturing chief granted 125,208 RSUs and exercises awards
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Organon & Co. interim executive Juliana Papa reported a large equity compensation grant and related vesting activity. On March 31, 2026, she received 125,208 restricted stock units (RSUs), each representing a contingent right to one share of Organon common stock. These RSUs will vest in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029.
On the same date, previously granted RSUs vested and were converted into common shares through exercises of 6,378 and 10,073 RSUs. To cover tax obligations, 2,185 and 3,451 common shares were withheld at a price of $5.70 per share. After these transactions, Papa directly holds 33,235.703 shares of common stock and 20,148 RSUs.
Positive
- None.
Negative
- None.
Insider Trade Summary
16,451 shares exercised/converted
Mixed
7 txns
Insider
Drinane Juliana Papa
Role
Interim Head of Mfg & Supply
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 125,208 | $0.00 | -- |
| Exercise | Restricted Stock Units | 6,378 | $0.00 | -- |
| Exercise | Restricted Stock Units | 10,073 | $0.00 | -- |
| Exercise | Common Stock | 6,378 | $0.00 | -- |
| Tax Withholding | Common Stock | 2,185 | $5.70 | $12K |
| Exercise | Common Stock | 10,073 | $0.00 | -- |
| Tax Withholding | Common Stock | 3,451 | $5.70 | $20K |
Holdings After Transaction:
Restricted Stock Units — 125,208 shares (Direct);
Common Stock — 28,798.703 shares (Direct)
Footnotes (1)
- This price is the closing market price of Organon & Co. ("Organon") common stock on Monday, March 30, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded. On March 31, 2026, the Reporting Person was granted 125,208 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029. Each RSU represents a contingent right to receive one share of Organon common stock. On March 31, 2023, the Reporting Person was granted 19,132 RSUs. Two-thirds of such RSUs previously vested, and the remaining one-third vested on March 31, 2026. On March 31, 2025, the Reporting Person was granted 30,221 RSUs. One-third of such RSUs vested on March 31, 2026, with the remaining two-thirds to vest on March 31, 2027 and March 31, 2028.
Key Figures
New RSU grant: 125,208 RSUs
RSUs vesting schedule: 3 equal installments
RSUs exercised: 6,378 and 10,073 RSUs
+4 more
7 metrics
New RSU grant
125,208 RSUs
Granted March 31, 2026 to interim Head of Mfg & Supply
RSUs vesting schedule
3 equal installments
Vesting on March 31, 2027, 2028, and 2029
RSUs exercised
6,378 and 10,073 RSUs
Converted into Organon common stock on March 31, 2026
Tax-withheld shares
2,185 and 3,451 shares
Withheld at $5.70 per share for tax obligations
Common shares held
33,235.703 shares
Direct holdings after March 31, 2026 transactions
Remaining RSUs
20,148 RSUs
Unvested RSUs outstanding after exercises disclosed
Reference price
$5.70 per share
Closing price on March 30, 2026 used for tax-withholding
Key Terms
Restricted Stock Units, contingent right, tax-withholding disposition, exercise or conversion of derivative security
4 terms
Restricted Stock Units financial
"On March 31, 2026, the Reporting Person was granted 125,208 RSUs"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each RSU represents a contingent right to receive one share of Organon common stock."
tax-withholding disposition financial
"Payment of exercise price or tax liability by delivering securities"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
exercise or conversion of derivative security financial
"Exercise or conversion of derivative security"
FAQ
What did Organon (OGN) interim executive Juliana Papa receive in this Form 4 filing?
Juliana Papa received a grant of 125,208 restricted stock units (RSUs). Each RSU is a contingent right to one Organon common share, vesting in three equal installments on March 31, 2027, 2028, and 2029, reflecting a multi-year equity compensation award.
How do the new RSUs for Juliana Papa at Organon (OGN) vest over time?
The 125,208 RSUs vest in three equal annual installments. They become exercisable in thirds on March 31, 2027, March 31, 2028, and March 31, 2029. This structure encourages long-term retention and aligns compensation with Organon’s future performance over several years.
What RSU vesting activity did the Organon (OGN) Form 4 disclose for March 31, 2026?
RSUs from 2023 and 2025 grants vested on March 31, 2026. A remaining one-third of a 19,132-RSU grant from March 31, 2023 and one-third of a 30,221-RSU grant from March 31, 2025 vested, then were exercised into Organon common shares.